Pyridoxalated haemoglobin polyoxyethylene

N/A

Report date: 2022/11/25 17:24:10
NME

Base Information

Drug NamePyridoxalated haemoglobin polyoxyethylene
Drug Alias NamePHP-HTPHP-CTPHPPHP-OCVTR-PHP
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionNitric oxide inhibitors
TargetsNot applicable
Therapy Area/IndicationsShockSystemic Inflammatory Response Syndrome
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPending (Phase 3 Clinical)
Highest Status in ChinaN/A
Originator CompaniesAjinomoto Co Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesApex Bioscience Inc
Active IndicationsN/A
Inactive IndicationsShockSystemic Inflammatory Response Syndrome

Other Information

ATC CodeN/A
Related LinksN/A